Creo Medical Limited
CREO.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | £2,200 | – | £15,200 | £15,100 |
| % Growth | – | – | 0.7% | – |
| Cost of Goods Sold | £1,200 | – | £8,000 | £7,300 |
| Gross Profit | £1,000 | – | £7,200 | £7,800 |
| % Margin | 45.5% | – | 47.4% | 51.7% |
| R&D Expenses | £0 | – | £0 | £11,900 |
| G&A Expenses | £11,000 | – | £20,800 | £19,600 |
| SG&A Expenses | £11,000 | – | £20,800 | £19,600 |
| Sales & Mktg Exp. | £0 | – | £0 | £0 |
| Other Operating Expenses | -£26,200 | – | £100 | -£12,300 |
| Operating Expenses | -£15,200 | – | £20,900 | £19,200 |
| Operating Income | -£10,000 | – | -£13,700 | -£11,800 |
| % Margin | -454.5% | – | -90.1% | -78.1% |
| Other Income/Exp. Net | £26,100 | – | -£100 | £500 |
| Pre-Tax Income | £16,100 | – | -£13,800 | -£11,300 |
| Tax Expense | £800 | – | -£1,500 | -£1,200 |
| Net Income | £16,900 | – | -£12,300 | -£10,100 |
| % Margin | 768.2% | – | -80.9% | -66.9% |
| EPS | 0.041 | – | -0.034 | -0.028 |
| % Growth | – | – | -21% | – |
| EPS Diluted | 0.041 | – | -0.034 | -0.028 |
| Weighted Avg Shares Out | 422,511 | – | 361,669 | 359,533 |
| Weighted Avg Shares Out Dil | 415,638 | – | 361,664 | 359,525 |
| Supplemental Information | – | – | – | – |
| Interest Income | £300 | – | £0 | £400 |
| Interest Expense | £100 | – | £0 | £300 |
| Depreciation & Amortization | £500 | – | £1,800 | £1,700 |
| EBITDA | -£9,500 | – | -£11,800 | -£9,300 |
| % Margin | -431.8% | – | -77.6% | -61.6% |